MedTrace Logo

Pubertal Induction in Individuals With Hypogonadism

NCT02871986 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 24

Last updated 2016-08-18

No results posted yet for this study

Summary

The investigators wish to explore the variability of uterine, breast and bone outcome markers as surrogates to assess the adequacy of exogenous oestrogen replacement in individuals with hypogonadism.

Conditions

  • Primary Amenorrhoea
  • Hypothalamic Amenorrhoea
  • Hypogonadotrophic Hypogonadism
  • Hypopituitarism
  • Turner's Syndrome
  • Primary Ovarian Insufficiency

Interventions

DRUG

Routine transdermal oestrogen patch

Transdermal oestrogen patch will be used with an incremental dose increase at 4 months

Sponsors & Collaborators

  • University College, London

    lead OTHER

Principal Investigators

  • Gerard Conway, FRCP, MD · UCL

Eligibility

Min Age
10 Years
Max Age
30 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-09-30
Primary Completion
2018-03-31
Completion
2020-03-31

Countries

  • United Kingdom

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02871986 on ClinicalTrials.gov